|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash | |||||||||||||||||||
| Total Current Assets | |||||||||||||||||||
| Equipment, net of accumulated depreciation of $307 and $251 at December 31, 2025 and 2024, respectively | |||||||||||||||||||
| Operating lease right-of-use asset | |||||||||||||||||||
| Security deposit | |||||||||||||||||||
| TOTAL ASSETS | |||||||||||||||||||
| LIABILITIES AND STOCKHOLDER’S DEFICIT | |||||||||||||||||||
| Liabilities | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||||
| Due to related parties | |||||||||||||||||||
| Sanovas Ophthalmology LLC | |||||||||||||||||||
| Related Party | |||||||||||||||||||
| Shareholders’ notes payable | |||||||||||||||||||
| Operating lease liability – current portion | |||||||||||||||||||
| Accrued interest payable | |||||||||||||||||||
| Total Current Liabilities | |||||||||||||||||||
| Operating lease liability – long term portion | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholder’s Deficit: | |||||||||||||||||||
| Common stock, $0.0001 par value; 80,000,000 shares authorized; 18,843,628 shares issued and outstanding at June 30, 2026 and December 31, 2025 | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Stock subscription receivable | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total Stockholders’ Deficit | |||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||||||||||||||
Loading...
